Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma

• Jan-Michael Werner,
• Viola Schweinsberg,
• Michael Schroeter,
• Michael Schroeter,
• Boris von Reutern,
• Michael P. Malter,
• Max Schlaak,
• Max Schlaak,
• Gereon R. Fink,
• Gereon R. Fink,
• Cornelia Mauch,
• Cornelia Mauch,
• Norbert Galldiks,
• Norbert Galldiks,
• Norbert Galldiks

Affiliations

Jan-Michael Werner

Department of Neurology, University of Cologne, Cologne, Germany

Viola Schweinsberg

Department of Dermatology, University of Cologne, Cologne, Germany

Michael Schroeter

Department of Neurology, University of Cologne, Cologne, Germany

Michael Schroeter

Center of Integrated Oncology, University of Cologne, Cologne, Germany

Boris von Reutern

Department of Neurology, University of Cologne, Cologne, Germany

Michael P. Malter

Department of Neurology, University of Cologne, Cologne, Germany

Max Schlaak

Department of Dermatology, University of Cologne, Cologne, Germany

Max Schlaak

Center of Integrated Oncology, University of Cologne, Cologne, Germany

Gereon R. Fink

Department of Neurology, University of Cologne, Cologne, Germany

Gereon R. Fink

Institute of Neuroscience and Medicine (INM-3), Forschungszentrum Juelich, Juelich, Germany

Cornelia Mauch

Department of Dermatology, University of Cologne, Cologne, Germany

Cornelia Mauch

Center of Integrated Oncology, University of Cologne, Cologne, Germany

Norbert Galldiks

Department of Neurology, University of Cologne, Cologne, Germany

Norbert Galldiks

Center of Integrated Oncology, University of Cologne, Cologne, Germany

Norbert Galldiks

Institute of Neuroscience and Medicine (INM-3), Forschungszentrum Juelich, Juelich, Germany